Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 2/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7293029 | 0.99 | SIGMAR1 (0.40) | SIGMAR1DPP4DPP7HTR2COPRD1 | |
| SCHEMBL6301700 | 0.88 | SIGMAR1 (0.42) | SIGMAR1DPP4DPP7HTR2CHTR2A | |
| SCHEMBL2885089 | 0.85 | SIGMAR1 (0.41) | SIGMAR1DPP4DPP7HTR2CCA1 | |
| SCHEMBL10772014 | 0.85 | ALDH1A1 (0.50) | SIGMAR1DPP4DPP7HTR2CHTR2A | |
| SCHEMBL27843488 | 0.81 | SLC6A2 (0.41) | SIGMAR1HTR2CHTR2AHTR2BCYP2D6 | |
| Hydrochloric Acid SCHEMBL28338297 | 0.81 | MAPT (0.41) | OPRD1TACR1 | |
| SCHEMBL27760304 | 0.80 | OPRM1 (0.40) | HTR2COPRD1HTR2AHTR2BTACR1 | |
| SCHEMBL6190053 | 0.80 | SIGMAR1 (0.43) | SIGMAR1ALDH1A1HSD17B10RIPK1 | |
| SCHEMBL16908331 | 0.79 | CA1 (0.55) | DPP4DPP7CA1CA2CA4 | |
| SCHEMBL1923622 | 0.79 | HTR2C (0.40) | DPP4DPP7HTR2CHTR2AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102391169-B | The preparation method of N-(5-methoxyl group-3-indolylethyl)-4-substituted phenylpiperazine-1-ethanamide | SHANGHAI CHEMICAL REAGENT INST. (CN) | 2015-10-28 | — | — | CN | disclosed |
| US-20150203590-A1 | LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS AND METHODS OF USE | DIAZYME LABORATORIES, INC. | 2015-07-23 | — | — | US | disclosed |
| US-9000132-B2 | Lipoprotein-associated phospholipase A2 antibody compositions and methods of use | DIADEXUS, INC. (US) | 2015-04-07 | — | — | US | disclosed |
| WO-2014144040-A1 | LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS AND METHODS OF USE | DIADEXUS, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140283157-A1 | LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS AND METHODS OF USE | DIADEXUS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275485-A1 | LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS AND METHODS OF USE | DIADEXUS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130236450-A1 | Methods Using Lipoprotein-Associated Phospholipase A2 in an Acute Care Setting | MONTANER JOAN (ES) | 2013-09-12 | — | — | US | disclosed |
| EP-1718967-B1 | METHODS OF DETECTING Lp-PLA2 ACTIVITY | DIADEXUS INC (US) | 2013-04-24 | — | — | EP | disclosed |
| EP-2563914-A1 | METHODS USING LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN AN ACUTE CARE SETTING | Diadexus, Inc. (US) | 2013-03-06 | — | — | EP | disclosed |
| CN-102391169-A | Method for preparing N-(5-methoxy-1H-indole-3-ethyl)-4-subtituted phenylpiperazine-1-acetamide | SHANGHAI CHEMICAL REAGENT RES INST | 2012-03-28 | — | — | CN | disclosed |
| WO-2011137419-A1 | METHODS USING LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN AN ACUTE CARE SETTING | DIADEXUS, INC. (US) | 2011-11-03 | — | — | WO | disclosed |
| EP-2280282-A1 | Methods of detecting Lp-PLA2 activity | Diadexus, Inc. (US) | 2011-02-02 | — | — | EP | disclosed |
| EP-1718967-A4 | METHODS OF DETECTING Lp-PLA2 ACTIVITY | DIADEXUS INC (US) | 2008-03-05 | — | — | EP | disclosed |
| US-20070281323-A1 | Methods Of Detecting Lp-PLA2 Activity | DIAZYME LABORATORIES, INC. | 2007-12-06 | — | — | US | disclosed |
| EP-1718967-A2 | METHODS OF DETECTING Lp-PLA2 ACTIVITY | Diadexus, Inc. (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005074604-A2 | METHODS OF DETECTING Lp-PLA2 ACTIVITY | DIADEXUS, INC. (US) | 2005-08-18 | — | — | WO | disclosed |
| US-4567264-A | ADRENERGIC BLOCKING AGENTS | SYNTEX (U.S.A.) INC. (US) | 1986-01-28 | — | — | US | disclosed |
| US-4558129-A | Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade | SYNTEX (U.S.A.) INC. (US) | 1985-12-10 | — | — | US | disclosed |
| EP-0126449-A1 | Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry | SYNTEX (U.S.A.) INC. (US) | 1984-11-28 | — | — | EP | disclosed |